Description:NebuSelect™ Recombinant Human VLDLR, His-tag(Cat#NBL-241966) is expressed in HEK293 with His tag at the C-Terminus.It contains Gly28-Ser797.

Species:Human

Expression System:HEK293

Molecular Weight: The protein has a predicted MW of 85.9 kDa. Due to glycosylation, the protein migrates to 115-125 kDa based on Bis-Tris PAGE result.

Target Name:VLDLRSynonymsVLDL-R; VLDLR; RP11-320E16.1; CHRMQ1; FLJ35024; VLDLRCH

Target Information:VLDLR cerebellar hypoplasia (VLDLR-CH) is characterized by non-progressive congenital ataxia that is predominantly truncal and results in delayed ambulation, moderate-to-profound intellectual disability, dysarthria, strabismus, and seizures.VLDLR-CH is inherited in an autosomal recessive manner. Carrier testing for at-risk relatives, prenatal testing for a pregnancy at increased risk and preimplantation genetic testing are possible when the pathogenic variants in a family are known.

Amino Acid Sequence: Gly28-Ser797

Purity:＞95%

Endotoxin:＜1EU/ug(LAL Method)